Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Trolard vein thrombosis: A case report

Breadcrumb

  • Home
  • Trolard vein thrombosis: A case report

Feras Sha'aban 1, Rakan Al-Lozi 1, Assem Al-Njeiden Al-Btoush 1, Khalid Abu Romman 1, Esra'a Al-Habashneh 1, Doaa Al-Shurbaji 2 and Tareq Bani Khalid 1 *,

1 Department of Surgery, Neurosurgery Subdepartment, King Hussein Medical Center, Royal Medical Services, Amman, Jordan.
2 Department of Medical Laboratory, King Hussein Medical Center, Royal Medical Services, Amman, Jordan.
 

Case Report

World Journal of Biology Pharmacy and Health Sciences, 2025, 23(01), 171–183

Article DOI: 10.30574/wjbphs.2025.23.1.0642

DOI url: https://doi.org/10.30574/wjbphs.2025.23.1.0642

Received on 20 June 2025; revised on 05 July 2025; accepted on 08 July 2025

An uncommon condition that has the potential to be fatal is known as 'cerebral venous thrombosis' (CVT).  Bleeding and damage to veins are also possible outcomes. There is a significant venous draining pathway known as the superior anastomotic vein, also known as the vein of Trolard. This vein links the superficial middle cerebral vein to the superior sagittal sinus.  In spite of the fact that thrombosis in this vein is very rare, it has the potential to obstruct the flow of blood out of the body and contribute to significant neurological disorders.  A lady who is forty years old and has just begun taking oral contraceptives is the subject of our attention.  Due to the fact that her type 2 diabetes mellitus (HbA1c 8.6%) was not being treated, she recently suffered from Trolard vein thrombosis with haemorrhagic conversion.  In addition to having a bad headache, the patient had difficulty speaking and moving their lips, and they experienced a little weakness on the right side of their body.  It was determined via imaging that the tumour located on the left parietal region was packed with thrombosis and had bleeding that had reached the superior sagittal sinus system.  During the time that she was receiving split heparin and coumadin, she was under strict observation for any symptoms of brain damage.  In this particular instance, it is shown how vital it is to detect CVT in those who are at a high risk, as well as how essential it is to provide anticoagulation even while there is bleeding.

Cerebral Venous Thrombosis (CVT); Trolard Vein Thrombosis; Hemorrhagic Conversion; Oral Contraceptives (Risk Factor); Anticoagulation Therapy

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2025-0642.pdf

Preview Article PDF

Feras Sha'aban, Rakan Al-Lozi, Assem Al-Njeiden Al-Btoush, Khalid Abu Romman, Esra'a Al-Habashneh, Doaa Al-Shurbaji and Tareq Bani Khalid. Trolard vein thrombosis: A case report. World Journal of Biology Pharmacy and Health Sciences, 2025, 23(01), 171-183. Article DOI: https://doi.org/10.30574/wjbphs.2025.23.1.0642.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution